• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 78 of 100
The Two Mercks Are Locking Horns in a Naming Trademark Spat
HealthThe Two Mercks Are Locking Horns in a Naming Trademark Spat
By Sy MukherjeeApril 18, 2016
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
FinanceAstraZeneca Is Eyeing This San Francisco Drugmaker
By ReutersApril 18, 2016
Apple Again Pushes Back Against Unlocking iPhone in New York Drug Case
TechApple Again Pushes Back Against Unlocking iPhone in New York Drug Case
By ReutersApril 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant Talking to Investment Banks to Weigh Asset Sales
By ReutersApril 15, 2016
Inside of a Gilead Sciences Lab
HealthThe FDA Wants Pharma to Ditch its Archaic Drug Making Process
By Sy MukherjeeApril 14, 2016
Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market
HealthU.S. Drug Spending Hits Record High (Again)
By Erika FryApril 14, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthValeant’s CEO Just Avoided Contempt Charges From the U.S. Senate
By ReutersApril 13, 2016
Here’s Why Shares of This Hot Biopharma Are Jumping
FinanceHere’s Why Shares of This Hot Biopharma Are Jumping
By Lucinda ShenApril 13, 2016
House Oversight Hearing On Prescription Drug Price Increases
HealthFormer Shkreli-Led Drug Developer Pledges Responsible Pricing
By ReutersApril 11, 2016
Apple Starts iPhone 6 Sales In Germany
TechA New Smartphone App Promises Help for Schizophrenia
By David Z. MorrisApril 9, 2016
Stocks Continue Downward Slide On Heels Of Yesterday's Extreme Fall
FinanceIntercept Pharma’s Shares Spike Before Falling On Key FDA Panel Backing
By Sy MukherjeeApril 8, 2016
The CEO of Valeant Pharmaceuticals has suggested that Allergan is fat, overstaffed and ripe for big
HealthAllergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed
By Sy MukherjeeApril 7, 2016
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
HealthA Federal Judge Dismissed More Than 300 Lawsuits Against Pfizer
By Sy MukherjeeApril 7, 2016
Losses mount for U.S. stocks.
FinanceThis Pharma Company’s Stock Is Popping for No Clear Reason
By Sy MukherjeeApril 7, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
HealthCancer Treatment Costs Aren’t Rising as Fast as You Thought
By Laura LorenzettiApril 6, 2016
1...
  • 76
  • 77
  • 78
  • 79
  • 80
...100
Most Popular
Personal Finance
Current price of oil as of June 17, 2026placeholder alt text
By Joseph HostetlerJune 17, 2026
Success
'Work hard, stay loyal, and the system will reward you': the Boomer credo is a Gen X betrayal and a Millennial pipe dreamplaceholder alt text
By Nick LichtenbergJune 16, 2026
Big Tech
Hundreds of Stanford students walked out of their grad ceremony to protest Google CEO’s commencement speech. It wasn’t all about AIplaceholder alt text
By Tristan BoveJune 15, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.